Search
Close this search box.

What is happening at Pivot Park?

News

Search

Categories

Marion Koopmans
News

Leaders in Life Sciences – #12 Marion Koopmans

In de Leaders of Life Sciences Podcast gaat André van de Sande in gesprek met leiders van nu en straks in de life sciences sector. Wij zijn ervan overtuigd dat er meer open gesproken moet worden door mensen uit de sector over henzelf maar ook over hun werk. Dat begint bij de leiders van nu die in de podcast bevraagd worden over hun carrière en drijfveren. Het zijn leiders die allen werkzaam zijn in de breedste uithoeken van de sector, maar één ding hebben ze allemaal gemeen: onze gasten hebben allemaal een missie om bij te dragen aan het verbeteren van de gezondheid wereldwijd. Hoe doen ze dit en is hiervoor begrip? In aflevering 12 is onze gast: Marion Koopmans, Virologe en Hoofd van de afdeling Viroscience aan het ErasmusMC.

Read More »
Pharming announced approval Joenja
News

Pharming announces US FDA approval of Joenja® (leniolisib) as the first and only treatment indicated for APDS

Pharming Group N.V. announces that the US Food and Drug Administration (FDA) has approved Joenja® (leniolisib) for the treatment of activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS) in adult and pediatric patients 12 years of age and older. Joenja®, an oral, selective PI3Kδ inhibitor, is the first and only treatment approved in the US for APDS, a rare and progressive primary immunodeficiency.

Read More »
Get to know Rescop
News

Get to know: Rescop

Rescop, established in 2005 by two experienced corporate auditors from the pharmaceutical industry, offers innovative solutions for GxP regulatory compliance. Their passion for quality management software led to the founding of Rescop, which now provides a wide range of consulting services to support GxP regulated companies in establishing and maintaining compliance in a highly efficient manner. By combining consulting services with software products, Rescop offers a unique portfolio of quality management solutions suitable for businesses of all sizes and stages of maturity.

Read More »
Synaffix collaboration
News

Synaffix Announces Expansion of ADC Collaboration with MacroGenics

Synaffix announces the expansion of their collaboration with biopharmaceutical company MacroGenics, Inc., to a value of up to $2.2B plus up to high single-digit royalties. Under this new expanded deal, MacroGenics, Inc. will pursue up to seven of the ADC programs, helping to further contribute towards the transformation of cancer treatment.

Read More »
Grizzly building
News

Press release: Reaching big heights at Pivot Park

The new Grizzly building has reached it’s highest point at Pivot Park this week. Grizzly provides space for offices and laboratories. This space is much needed, because successful start-ups and scale-ups are outgrowing their space. With the arrival of Grizzly, Pivot Park stimulates innovation and employment. Companies will have the space and facilities to develop further. This allows them to excel further and to continue to play a leading role worldwide in the field in which they operate.

Read More »
News

Get to know: Pedersen & Partners

Pedersen & Partners is a leading global Executive Search, Leadership Consulting and Board Services firm Pedersculturally diverse and committed to Diversity & Inclusion. With close to 400 colleagues around the world, it is operating 54 wholly owned offices in 50 countries across Europe, the Middle East, Africa, Asia & the Americas. Founded in 2001 by Poul Pedersen, Pedersen & Partners has applied the values Trust – Relationship – Professionalism to our interactions with clients and executives, as well as internally.

Read More »

Pivot Park Captains' Dinner

10 years ago, Pivot Park opened its doors to the world. Thanks to your commitment, support and confidence, we have been able to grow it into the successful and innovative biopharmaceutical campus it is today.

Now it’s time to celebrate!

We are therefore delighted to invite you – along with all your fellow CEOs at Pivot Park – to a special night out featuring inspiring art, a wonderful dinner and lots of opportunities to network and exchange ideas.

Erwin Wurm | Am I a House?

For the first time, the artist shows a cross-section of his work, from Narrow Furniture to One Minute Sculptures, within the walls of a historic building. Villa Constance, a former home that today houses Museum Jan Cunen, is not only a location but also part of the conversation. Because what exactly is a house?

#100YEARSPHARMAFUTURE

The development of medicines in Oss began one hundred years ago. It was then that the foundations were laid for what would become a flourishing pharmaceutical sector in the Netherlands, leading to groundbreaking discoveries such as insulin and the anti-conception pill.

Today, the entire chain is still represented in Oss, from early-stage research to the commercial scale production of medicines. Working in Oss, we focus on the health of people all over the world. Employees at dozens of companies large and small put their heart and soul into new medicines, products and services that will improve lives worldwide. Together, our strength lies in our combination of broad knowledge about the development of medicines and a thorough understanding of the requirements of high-quality production.

This shared past and common values stimulate strong bonds among everyone who works in pharmaceuticals in Oss. We build on qualities, expertise and networks that go back decades. And with a wide variety of pharmaceutical companies, suppliers and scientific institutions all located nearby, we offer an attractive business climate and an excellent basis for international collaboration.

We are proud to work together to create a better and healthier future for all, a collaboration that in turn fuels growing employment: today, most pharmaceutical jobs in the Netherlands are in Oss. Here we connect talent and companies and stimulate entrepreneurship, while our expert employees are our most important asset. Their drive ensures that Oss has an influence on health all over the world.

Pharma in Oss offers endless opportunities to startups and talent in a city and region that is a joy to live and work in. We are committed to collaboration and sustainable and successful entrepreneurship. Oss’s pharmaceutical companies are intrinsically competitive while also being committed to quality and safety. This, plus their focus on new health solutions and contemporary technology, makes us a leader in our pursuit of a better life for people worldwide.